RecruitingPhase 2NCT05925257

Digital Health Intervention to Improve Health Care and Outcomes for Breast Cancer Patients

Design and Evaluation of the Effectiveness of a Digital Health Intervention to Improve Health Care and Outcomes for Cancer Patients


Sponsor

Coordinación de Investigación en Salud, Mexico

Enrollment

410 participants

Start Date

Mar 5, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Background: Nearly 30,000 Mexican women develop breast cancer annually. These patients frequently present multiple unmet supportive care needs. In high-income settings, incorporating electronic patient-reported outcomes (ePROs) into cancer care has demonstrated potential for increasing patient-centred care and reducing unmet needs. No such ePRO interventions have been implemented in Mexico. The objectives of this study are (I) to design a two-component intervention for monitoring ePROs among breast cancer patients using a responsive digital application and proactive follow-up by nurses, (II) to perform intervention pilot testing of the study materials, and (III) to conduct the clinical trial to assess usability and effectiveness of the intervention. Methods. The investigators designed a two-component intervention for women receiving breast cancer treatment: a responsive web application for monitoring ePROs and clinical algorithms guiding proactive follow-up by nurses. The investigators will conduct a pilot test of the intervention with 50 breast cancer patients for six weeks to assess the feasibility and inform intervention adaptations. After that, the investigators will conduct a parallel arm randomized controlled trial assigning 205 patients each to intervention and control in one of Mexico's largest public oncology hospitals. The intervention will be provided for six months, with additional three months of post-intervention observation. The control group will receive usual healthcare and a list of information sources on relevant breast cancer topics. Women diagnosed with stages I, II, or III breast cancer who initiate chemo and/or radiotherapy will be invited to participate. The study outcomes will include supportive care needs, quality of life, use of emergency services and unscheduled hospitalizations, the usability of the ePRO App, and adherence to the intervention. Information on the outcomes will be obtained through web-based self-administered questionnaires collected at baseline, 1, 3, 6, and 9 months.


Eligibility

Sex: FEMALEMin Age: 20 YearsMax Age: 75 Years

Inclusion Criteria6

  • Women
  • Age between 20 and 75 years
  • Breast cancer stages I, II, or III
  • Neoadjuvant or adjuvant treatment with chemotherapy that started within two to six weeks before enrollment
  • Access to the internet on mobile phone, computer or tablet
  • Written informed consent

Exclusion Criteria5

  • Illiterate
  • Stage IV breast cancer
  • Cognitive dysfunction
  • Blindness or low vision not corrected with glasses
  • Severe depression (≥12 points on the Hospital Anxiety and Depression Scale)

Interventions

OTHERePRO application and proactive clinical care with nurses.

The investigators defined ePRO intervention as a weekly register of breast cancer patients' symptoms and supportive care needs using the study ePRO App combined with proactive follow-up by nurses guided by predefined clinical algorithms and a weekly cellphone message providing an educational video from a recognised cancer association or health institution. The intervention will be provided for six months with additional three months of post-intervention observation.


Locations(3)

Hospital de Oncología del Centro Médico Nacional Siglo XXI

Mexico City, Mexico City, Mexico

UMAE Hospital de Gineco-Obstetricia No.3 "Dr. Víctor Manuel Espinoza de los Reyes Sánchez" CMN La Raza.

Mexico City, Mexico

UMAE Hospital de Especialidades CMN "Gral. de Div. Manuel Ávila Camacho"

Puebla City, Mexico

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05925257


Related Trials